This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealthcare Regulation · Healthcare during COVID-19 Pandemic
The journal retracts the 18 December 2024 article cited above.
Following publication, concerns were raised regarding the scientific validity of the article. An investigation was conducted in accordance with Frontiers' policies.
The authors failed to provide a satisfactory explanation and as a result, the conclusions of the article have been deemed unreliable and the article has been retracted.
Furthermore, Luiz Antônio Camacho requested to be removed from the Acknowledgements section stating that, though consulted on an early draft of the manuscript, did not endorse the methods in the study.
The Postgraduate Program in Public Health of the Escola Nacional de Saúde Pública Sergio Arouca da Fundação Oswaldo Cruz (PPSP/ENSP/FIOCRUZ) requested to be removed from the Acknowledgments and Funding sections, stating that the article did not receive funding for research or publication.
This retraction was approved by the Chief Editors of Frontiers in Medicine and the Chief Executive Editor of Frontiers. The authors agree to this retraction.